Home | Welcome to Contract Pharma   
Last Updated Wednesday, July 23 2014
Print

Breaking News

Gil Roth
June 27, 2011
Discover collaboration began in April 2009 for molecules targeting CV, CNS, urology   Read More »
Gil Roth
June 27, 2011
Co-founder Hinchen to succeed Peter Jenkins  Read More »
Gil Roth
June 24, 2011
RCB to use maxXpress to help develop fusion protein for autoimmune indications  Read More »
Gil Roth
June 24, 2011
Three-year deal covers development-stage cancer drugs, may lead to companion diagnostics  Read More »
Gil Roth
June 24, 2011
State-of-the-art site, validated in 2009, will initially be used for Phase III supplies  Read More »
Gil Roth
June 24, 2011
Second complete response letter for ER oxycodone  Read More »
June 24, 2011
Reed-Lane has redesigned its website.  Read More »
June 23, 2011
Octagon Research Solutions, Inc. is expanding globally by adding 100 clinical and regulatory professionals, and expanding its U.S. headquarters, and opening new facilities in the UK and India.  Read More »
June 23, 2011
Neuland Laboratories Ltd. has expanded its manufacturing capabilities for synthetic peptides.   Read More »
June 23, 2011
Jubilant Biosys Ltd., a subsidiary of Jubilant Life Sciences Ltd., has successfully completed an early stage milestone in its neuroscience collaboration with AstraZeneca in the pain therapeutic area.  Read More »
Gil Roth
June 23, 2011
Injectables CMO cleared for Schedule II through V handling  Read More »
Gil Roth
June 22, 2011
Cancels NDA and MAA and withdraws MS treatment from approved markets  Read More »
Gil Roth
June 22, 2011
Dental, device business sells for $1.8 billion  Read More »
Gil Roth
June 22, 2011
Mitsubishi to gain 20% equity in new bio-CMO network, add global sales and marketing  Read More »
Gil Roth
June 21, 2011
Once-weekly diabetes injection cleared in EU  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On